IL18 and COVID-19: Following overnight stimulation with IL-12 and IL-18, IFN-γ production was only significantly decreased in patients with severe COVID-19 compared to healthy donors (p<0.0001), but return closed to the normal production at the second time-point (Pt2) (Figure 4B).